Insiders · Profile

Luu Brendan

Chief Business Officer at ENANTA PHARMACEUTICALS. Filing since 5 Dec 2023. CIK 0001842369

Company

Date

Role

Action

Amount

Of holding

5 Dec 2025

Chief Business Officer

Sold at will

1,394

$19.84K

3.5%

6 Dec 2024

Chief Business Officer

Sold on a plan

2,283

$18.40K

6.0%

5 Dec 2023

Sr. VP, Business Dev.

Sold at will

2,125

$20.46K

5.5%

3 decisions on file.